Summary Xceleron Inc (Xceleron), a subsidiary of Pharmaron Inc is a contract research organization that offers analytical solutions for drug development programs. The organization provides pharmaceutical services such as proof of concept, asset sale, asset purchase, and drug approval. It uses accelerator mass spectrometry technology to develop pharmaceutical products and detect minute drug traces in the blood, tissue, and body fluids. Xceleron's technology supports preclinical analysis for biologics or high potency drugs. It also offers biobased services and biobased testing services for various products and emissions. The organization serves pharmaceutical and biotechnology companies. Xceleron is headquartered in Germantown, Maryland, the US. Xceleron Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into... Research Beam Model: Research Beam Product ID: 2637773 250 USD New
Xceleron Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Xceleron Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : October   2017
  • Pages : 16
  • Publisher : GlobalData
 
 
 
Summary

Xceleron Inc (Xceleron), a subsidiary of Pharmaron Inc is a contract research organization that offers analytical solutions for drug development programs. The organization provides pharmaceutical services such as proof of concept, asset sale, asset purchase, and drug approval. It uses accelerator mass spectrometry technology to develop pharmaceutical products and detect minute drug traces in the blood, tissue, and body fluids. Xceleron's technology supports preclinical analysis for biologics or high potency drugs. It also offers biobased services and biobased testing services for various products and emissions. The organization serves pharmaceutical and biotechnology companies. Xceleron is headquartered in Germantown, Maryland, the US.

Xceleron Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Xceleron Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Xceleron Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Xceleron Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Xceleron Inc, Medical Devices Deals, 2011 to YTD 2017 8
Xceleron Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Xceleron Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Xceleron Raises US$2.4 Million In Venture Financing 10
Partnerships 11
Xceleron Enters Into Agreement With Crystal Pharmatech For Early Clinical Development 11
Acquisition 12
Pharmaron Acquires Xceleron 12
Xceleron Inc - Key Competitors 13
Xceleron Inc - Key Employees 14
Xceleron Inc - Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16
List of Tables
Xceleron Inc, Pharmaceuticals & Healthcare, Key Facts 2
Xceleron Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Xceleron Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Xceleron Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Xceleron Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Xceleron Inc, Medical Devices Deals, 2011 to YTD 2017 8
Xceleron Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Xceleron Raises US$2.4 Million In Venture Financing 10
Xceleron Enters Into Agreement With Crystal Pharmatech For Early Clinical Development 11
Pharmaron Acquires Xceleron 12
Xceleron Inc, Key Competitors 13
Xceleron Inc, Key Employees 14
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter